Importantly, the level of secreted IFN-γ has been used to evaluate the efficacy of the only FDA-approved therapeutic anti-cancer vaccine, PROVENGE® (sipuleucel-T), in a peptide-immunization study in mice (Saif et al., 2014). Here, IFNG is linked to cancer.